CRISPR Therapeutics AG
(CRSP - NASDAQ)
55,79 USD
📋 Profilo Aziendale

CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases.

|